In vitro evaluation of the susceptibility of Acinetobacter baumannii isolates to antiseptics and disinfectants: Comparison between clinical and environmental isolates

Antimicrobial Resistance and Infection Control

Volumn 6, Issue 1, 2017, Pages

  Lanjri, Sanae ^a   Uwingabiye, Jean ^a   Frikh, Mohammed ^a   Abdellatifi, Lina ^a   Kasouati, Jalal ^a   Maleb, Adil ^a   Bait, Abdelouahed ^a   Lemnouer, Abdelhay ^a   Elouennass, Mostafa ^a  

^a MOHAMMED V UNIVERSITY   (Morocco)

Author keywords

Acinetobacter baumannii; Antiseptics; Disinfectants; Resistance

Indexed keywords

ALCOHOL; ANTIINFECTIVE AGENT; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; DIDECYLDIMETHYLAMMONIUM CHLORIDE; DISINFECTANT AGENT; POVIDONE IODINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATION; BROTH DILUTION; CFU COUNTING; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; INOCULATION; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAMPLING;

EID: 85018647906     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/s13756-017-0195-y     Document Type: Article

References (22)

1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538.
2. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006;42(5):692-9.
3. Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, Vaneechoutte M. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol. 1997;35:2819-25.
4. Berlau J, Aucken H, Malnick H, Pitt T. Distribution of Acinetobacter species on skin of healthy humans. Eur J Clin Microbiol Infect Dis. 1999;18(3):179-83.
5. Bergogne-Bérézin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9(2):148-65.
6. Gaynes R, Edwards JR, National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis. 2005;41:848-54.
7. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309-17.
8. Uwingabiye J, Frikh M, Lemnouer A, Bssaibis F, Belefquih B, Maleb A, Dahraoui S, Belyamani L, Bait A, Haimeur C, Louzi L, Ibrahimi A, Elouennass M. Acinetobacter infections prevalence and frequency of the antibiotics resistance: comparative study of intensive care units versus other hospital units. Pan Afr Med J. 2016;23:191.
9. Rolain JM, Roch A, Castanier M, Papazian L, Raoult D. Acinetobacter baumannii resistant to colistin with impaired virulence: a case report from France. J Infect Dis. 2011;204:1146-7.
10. Elouennass M, Bajou T, Lemnouer AH, Foissaud V, Hervé V, Baaj AJ. Acinetobacter baumannii: étude de la sensibilité des souches isolées à l'hôpital militaire d'instruction Mohammed V, Rabat. Maroc Med Mal Infect. 2003;33:361-4.
11. Boyce JM, Pittet D, Healthcare Infection Control Practices Advisory Committee, HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep. 2002;51(RR-16):1-45.
12. Saperkin N, Kovalishena O, Blagonravova A. P089: surveillance of bacterial resistance to disinfectants. Antimicrob Resist Infect Control. 2013;2 Suppl 1:89.
13. Cardoso CL, Pereira HH, Zequim JC, Guilhermetti M. Effectiveness of hand-cleansing agents for removing Acinetobacter baumannii strain from contaminated hands. Am J Infect Control. 1999;27:327-31.
14. Mama M, Abdissa A, Sewunet T. Antimicrobial susceptibility pattern of bacterial isolates from wound infection and their sensitivity to alternative topical agents at Jimma University specialized hospital, South-West Ethiopia. Ann Clin Microbiol Antimicrob. 2014;13:14.
15. Wisplinghoff H, Schmitt R, Wöhrmann A, Stefanik D, Seifert H. Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii. J Hosp Infect. 2007;66(2):174-81.
16. Chung YK, Kim JS, Lee SS, Lee JA, Kim HS, Shin KS, Park EY, Kang BS, Lee HJ, Kang HJ. Effect of daily chlorhexidine bathing on acquisition of carbapenem-resistant Acinetobacter baumannii (CRAB) in the medical intensive care unit with CRAB endemicity. Am J Infect Control. 2015;43(11):1171-7.
17. Catalano M, Quelle LS, Jeric PE, Di Martino A, Maimone SM. Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic cases. J Hosp Infect. 1999;42:27-35.
18. Denton M, Wilcox MH, Parnell P, Green D, Keer V, Hawkey PM, Evans I, Murphy P. Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. J Hosp Infect. 2004;56:106-10.
19. Smith K, Gemmell CG, Hunter IS. The association between biocide tolerance and the presence or absence of qac genes among hospital-acquired and community-acquired MRSA isolates. J Antimicrob Chemother. 2008;61(1):78-84.
20. Block BB. Peroxygen compounds. In: Block SS, editor. Disinfection, sterilization, and preservation. 4th ed. Philadelphia, Pa, USA: Lea & Febiger; 1991. p. 167.
21. Reichel M, Schlicht A, Ostermeyer C, Kampf G. Efficacy of surface disinfectant cleaners against emerging highly resistant gram-negative bacteria. BMC Infect Dis. 2014;14:292.
22. Gilbert P, McBain AJ. Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clin Microbiol Rev. 2003;16(2):189-208.